Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego|December 12, 2002
[SEN virus--novel hepatotropic agent causing hepatitis?]Dariusz Marek Lebensztejn
Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego|May 6, 2003
[Contemporary opinions on liver fibrosis pathogenesis]Dariusz Marek Lebensztejn
Clinical and Experimental Hepatology|May 24, 2021
Non-alcoholic fatty liver disease and lipotoxicityNatalia Wasilewska, Dariusz Marek Lebensztejn
Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego|July 21, 2010
[Evaluation of serum visfatin concentrations in children with nonalcoholic fatty liver disease]Anna Romanowska, Dariusz Marek Lebensztejn
Clinical and Experimental Hepatology|March 28, 2019
Update on pathogenesis, diagnostics and therapy of nonalcoholic fatty liver disease in childrenMarta Flisiak-Jackiewicz, Dariusz Marek Lebensztejn
World Journal of Gastroenterology|March 8, 2006
Ultrastructure of Kupffer cells and hepatocytes in the Dubin-Johnson syndrome: a case reportMaria Elzbieta Sobaniec-Lotowska, Dariusz Marek Lebensztejn
Biomedicines|March 25, 2022
Chemerin as Potential Biomarker in Pediatric Diseases: A PRISMA-Compliant StudyKatarzyna Zdanowicz, Anna Bobrus-Chociej, Dariusz Marek Lebensztejn
Przeglad Epidemiologiczny|December 12, 2007
[Efficacy of combined antiviral therapy with interferon alfa and ribavirin in chronic hepatitis C patients with extrahepatic manifestations]Dorota Zarebska-Michaluk, Dariusz Marek Lebensztejn, Wiesław Kryczka
Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego|July 7, 2005
[The evaluation of hyaluronic acid and laminin concentration in serum in children with chronic hepatitis B treated with lamivudine, unresponsive to previous interferon-alpha therapy]Elzbieta Skiba, Dariusz Marek Lebensztejn, Irena Werpachowska, et al.
Pageof 5